tiprankstipranks
Trending News
More News >
Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)
:INDRAMEDCO
India Market
Advertisement

Indraprastha Medical Corporation Limited (INDRAMEDCO) Stock Statistics & Valuation Metrics

Compare
3 Followers

Total Valuation

Indraprastha Medical Corporation Limited has a market cap or net worth of ₹46.47B. The enterprise value is ₹36.49B.
Market Cap₹46.47B
Enterprise Value₹36.49B

Share Statistics

Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,673,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Indraprastha Medical Corporation Limited’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 22.35%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)22.35%
Return on Capital Employed (ROCE)0.30
Revenue Per Employee4.56M
Profits Per Employee540.78K
Employee Count2,977
Asset Turnover1.59
Inventory Turnover143.95

Valuation Ratios

The current PE Ratio of Indraprastha Medical Corporation Limited is 26.6. Indraprastha Medical Corporation Limited’s PEG ratio is 0.75.
PE Ratio26.6
PS Ratio2.66
PB Ratio6.04
Price to Fair Value6.04
Price to FCF29.92
Price to Operating Cash Flow0.00
PEG Ratio0.75

Income Statement

In the last 12 months, Indraprastha Medical Corporation Limited had revenue of 13.56B and earned 1.61B in profits. Earnings per share was 17.56.
Revenue13.56B
Gross Profit3.50B
Operating Income2.03B
Pretax Income2.16B
Net Income1.61B
EBITDA2.44B
Earnings Per Share (EPS)17.56

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Indraprastha Medical Corporation Limited pays an annual dividend of ₹4.5, resulting in a dividend yield of 0.88%
Dividend Per Share₹4.5
Dividend Yield0.88%
Payout Ratio29.07%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.18
52-Week Price Change17.05%
50-Day Moving Average529.04
200-Day Moving Average449.74
Relative Strength Index (RSI)38.31
Average Volume (3m)33.92K

Important Dates

Indraprastha Medical Corporation Limited upcoming earnings date is Feb 9, 2026, TBA (Confirmed).
Last Earnings DateNov 1, 2025
Next Earnings DateFeb 9, 2026
Ex-Dividend DateSep 18, 2025

Financial Position

Indraprastha Medical Corporation Limited as a current ratio of 2.41, with Debt / Equity ratio of 0.00%
Current Ratio2.41
Quick Ratio2.37
Debt to Market Cap0.00
Net Debt to EBITDA-0.12
Interest Coverage Ratio32.34

Taxes

In the past 12 months, Indraprastha Medical Corporation Limited has paid 553.30M in taxes.
Income Tax553.30M
Effective Tax Rate0.26

Enterprise Valuation

Indraprastha Medical Corporation Limited EV to EBITDA ratio is 14.63, with an EV/FCF ratio of 29.68.
EV to Sales2.64
EV to EBITDA14.63
EV to Free Cash Flow29.68
EV to Operating Cash Flow22.80

Balance Sheet

Indraprastha Medical Corporation Limited has ₹3.22B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹3.22B billion.
Cash & Marketable Securities₹3.22B
Total Debt₹0.00
Net Cash₹3.22B
Net Cash Per Share₹35.10
Tangible Book Value Per Share₹65.02

Margins

Gross margin is 26.86%, with operating margin of 14.95%, and net profit margin of 11.87%.
Gross Margin26.86%
Operating Margin14.95%
Pretax Margin15.95%
Net Profit Margin11.87%
EBITDA Margin18.01%
EBIT Margin14.74%

Analyst Forecast

The average price target for Indraprastha Medical Corporation Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast6.51%
EPS Growth Forecast18.24%

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis